| Name | (2S)-2-[(4S)-4-(2,2-difluoroethenyl)-2-oxopyrrolidin-1-yl]butanamide |
|---|---|
| Synonyms |
UNII-RFR2CH3QZK
Seletracetam Seletracetam (USAN/INN) |
| Description | Seletracetam (Ucb 44212) is an analog of the antiepileptic agent Levetiracetam. Seletracetam is a small molecule SV2A modulator for the research of epilepsy[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
SV2A[1] |
| In Vitro | Seletracetam decreases seizure activity in a number of epilepsy models and binds to the synaptic vesicle protein SV2A[2]. Seletracetam decreases synaptic responses in a time-, frequency- and concentration-dependent manner[2]. Seletracetam modifies rates of presynaptic release[2]. Seletracetam inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro[2]. |
| References |
| Molecular Formula | C10H14F2N2O2 |
|---|---|
| Molecular Weight | 232.22700 |
| Exact Mass | 232.10200 |
| PSA | 64.39000 |
| LogP | 1.96680 |
| HS Code | 2933790090 |
|---|
| HS Code | 2933790090 |
|---|---|
| Summary | 2933790090. other lactams. VAT:17.0%. Tax rebate rate:9.0%. . MFN tariff:9.0%. General tariff:20.0% |